Nexthera Capital’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Nexthera Capital’s Portfolio VCNX Stock Details VCNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-81	Closed	-$62K	–	31
2018 Q4	$62K	Hold	81	–	–	0.03%	23
2018 Q3	$124K	Buy	+81	New	+$167K	0.02%	56

Other funds holding VCNX

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Nexthera Capital's VCNX Position: Q1 2019 in Review

Nexthera Capital sold out of Vaccinex, Inc. Common Stock (VCNX) in Q1 2019, closing a stake of 81 shares — an estimated $62K sold.

Nexthera Capital first reported a position in VCNX in Q3 2018 and held it in 2 quarters. The position peaked at $124K in Q3 2018. 9 funds tracked by Wall St. Rank hold VCNX as of Q1 2019.

Nexthera Capital reported no remaining Vaccinex, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
Nexthera Capital sold 81 Vaccinex, Inc. Common Stock shares in Q1 2019, an estimated $62K.
Nexthera Capital first reported a position in Vaccinex, Inc. Common Stock in Q3 2018 and held it in 2 quarters.
Nexthera Capital's Vaccinex, Inc. Common Stock position peaked at $124K in Q3 2018.
9 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q1 2019.

Based on Nexthera Capital's 13F filing for Q1 2019, filed 15 May 2019.